Skip to content

Opening book details…

Can I read Video-assisted Thoracoscopic Surgery Is More Favorable Than Thoracotomy for Administration of Adjuvant Chemotherapy After Lobectomy for Non-small Cell Lung Cancer on EtoBox?

Video-assisted Thoracoscopic Surgery Is More Favorable Than Thoracotomy for Administration of Adjuvant Chemotherapy After Lobectomy for Non-small Cell Lung Cancer by Guanchao Jiang; Fan Yang; Xiao Li; Jun Liu; Jianfeng Li; Hui Zhao; Yun Li; Jun Wang is a Medicine article available to read on EtoBox.

What is Video-assisted Thoracoscopic Surgery Is More Favorable Than Thoracotomy for Administration of Adjuvant Chemotherapy After Lobectomy for Non-small Cell Lung Cancer about?

## Background Video-assisted thoracoscopic surgery (VATS) lobectomy is a newly developed type of surgery for lung cancer and has been demonstrated obvious minimally-invasive advantages compared with traditional thoracotomy. Theoretically, that less trauma leads to quicker recovery and may facilitate administration of adjuvant chemotherapy. We tested this hypothesis in this study. ## Methods One hundred and ten NSCLC patients underwent lobectomy and adjuvant chemotherapy from June 2004 to June 2010 was analyzed. The baseline characteristic criteria, variables related to surgery and accomplishing status of chemotherapy were analyzed. ## Results All 110 patients underwent lobectomy through VATS (n = 54) or thracotomy (n = 56) and adjuvant chemotherapy. There was no significant difference in patients' age, preoperative pulmonary function, co-morbidity, pathologic staging between the two groups, whereas, blood loss, operation time and postoperative complications, chest tube duration and length of stay were less in VATS group. There were no significant differences in time to initiation chemotherapy. Cases in VATS group received more cycles of chemotherapy (3.6 vs. 3.0, p = 0.002). A high

Who reads Video-assisted Thoracoscopic Surgery Is More Favorable Than Thoracotomy for Administration of Adjuvant Chemotherapy After Lobectomy for Non-small Cell Lung Cancer?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Guanchao Jiang; Fan Yang; Xiao Li; Jun Liu; Jianfeng Li; Hui Zhao; Yun Li; Jun Wang
Publisher
BioMed Central; Springer (Biomed Central Ltd.); London: BioMed Central, 2003-; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 1477-7819)
Published
2011
Language
EN
Field
Medicine (Health Sciences)

More by Guanchao Jiang; Fan Yang; Xiao Li; Jun Liu; Jianfeng Li; Hui Zhao; Yun Li; Jun Wang

Browse all works by Guanchao Jiang; Fan Yang; Xiao Li; Jun Liu; Jianfeng Li; Hui Zhao; Yun Li; Jun Wang